Dyne Therapeutics Inc. (DYN)
28.50
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 4 Dyne Therapeutics, Inc. For: Mar 25 Filed by: Cox John
March 27, 2024 4:25 PM - SEC Filing
Form 3 Dyne Therapeutics, Inc. For: Mar 25 Filed by: Cox John
March 27, 2024 4:15 PM - SEC Filing
Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer
March 27, 2024 4:05 PM - StreetInsider
Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium
March 27, 2024 8:30 AM - StreetInsider
Form 8-K Dyne Therapeutics, Inc. For: Mar 21
March 25, 2024 7:40 AM - SEC Filing
Dyne Therapeutics (DYN) Announces CEO Transition
March 25, 2024 7:30 AM - StreetInsider
Dyne Therapeutics Announces CEO Transition
March 25, 2024 7:30 AM - StreetInsider
Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days
March 13, 2024 7:30 AM - StreetInsider
Form 4 Dyne Therapeutics, Inc. For: Mar 08 Filed by: HIGH SUSANNA GATTI
March 13, 2024 6:05 AM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Mar 08 Filed by: McNeill Jonathan
March 13, 2024 6:05 AM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Mar 11 Filed by: Farwell Wildon
March 12, 2024 9:58 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Mar 08 Filed by: Scalzo Richard William
March 12, 2024 9:58 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Mar 08 Filed by: Brumm Joshua T
March 12, 2024 9:57 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Mar 11 Filed by: Beskrovnaya Oxana
March 12, 2024 9:43 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Farwell Wildon
March 12, 2024 4:15 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Mar 07 Filed by: Brumm Joshua T
March 11, 2024 9:58 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Mar 07 Filed by: Beskrovnaya Oxana
March 11, 2024 9:57 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Mar 07 Filed by: HIGH SUSANNA GATTI
March 11, 2024 9:57 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Mar 07 Filed by: Farwell Wildon
March 11, 2024 9:53 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Mar 07 Filed by: McNeill Jonathan
March 11, 2024 9:51 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Mar 07 Filed by: Scalzo Richard William
March 11, 2024 9:46 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Beskrovnaya Oxana
March 11, 2024 5:37 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Farwell Wildon
March 11, 2024 5:36 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: McNeill Jonathan
March 11, 2024 5:35 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Brumm Joshua T
March 11, 2024 5:34 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: HIGH SUSANNA GATTI
March 11, 2024 5:33 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Scalzo Richard William
March 11, 2024 5:32 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Scalzo Richard William
March 8, 2024 4:55 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: McNeill Jonathan
March 8, 2024 4:54 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: HIGH SUSANNA GATTI
March 8, 2024 4:53 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Brumm Joshua T
March 8, 2024 4:52 PM - SEC Filing
Dyne Therapeutics (DYN) PT Raised to $31 at Chardan Capital Markets
March 8, 2024 4:21 AM - StreetInsider
Form 144 Dyne Therapeutics, Inc. Filed by: Farwell Wildon
March 7, 2024 8:20 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Beskrovnaya Oxana
March 7, 2024 8:19 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Brumm Joshua T
March 7, 2024 8:18 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: HIGH SUSANNA GATTI
March 7, 2024 8:18 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Scalzo Richard William
March 7, 2024 8:17 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: McNeill Jonathan
March 7, 2024 8:17 PM - SEC Filing
Dyne Therapeutics (DYN) PT Raised to $29 at Piper Sandler
March 6, 2024 7:55 AM - StreetInsider
Form 4 Dyne Therapeutics, Inc. For: Mar 01 Filed by: Rhodes Jason P
March 5, 2024 5:08 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Mar 01 Filed by: Atlas Venture Opportunity Fund II, L.P.
March 5, 2024 5:07 PM - SEC Filing
Dyne Therapeutics (DYN) PT Raised to $41 at Stifel
March 5, 2024 4:48 PM - StreetInsider
Dyne Therapeutics (DYN) Files Mixed Shelf
March 5, 2024 8:25 AM - StreetInsider
Form S-3ASR Dyne Therapeutics, Inc.
March 5, 2024 8:22 AM - SEC Filing
Form 8-K Dyne Therapeutics, Inc. For: Mar 05
March 5, 2024 7:42 AM - SEC Filing
Form S-8 Dyne Therapeutics, Inc.
March 5, 2024 7:41 AM - SEC Filing
Dyne Therapeutics (DYN) PT Raised to $47 at Oppenheimer
March 5, 2024 7:41 AM - StreetInsider
Form 10-K Dyne Therapeutics, Inc. For: Dec 31
March 5, 2024 7:36 AM - SEC Filing
Dyne Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
March 5, 2024 7:30 AM - StreetInsider
Form 4 Dyne Therapeutics, Inc. For: Feb 29 Filed by: Brumm Joshua T
March 1, 2024 9:39 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Feb 29 Filed by: McNeill Jonathan
March 1, 2024 9:38 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Feb 29 Filed by: Scalzo Richard William
March 1, 2024 9:38 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Brumm Joshua T
March 1, 2024 9:34 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Scalzo Richard William
March 1, 2024 9:34 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: McNeill Jonathan
March 1, 2024 9:33 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
March 1, 2024 5:25 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
March 1, 2024 5:25 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Brumm Joshua T
February 29, 2024 7:55 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Scalzo Richard William
February 29, 2024 7:53 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: McNeill Jonathan
February 29, 2024 7:50 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Feb 26 Filed by: Rhodes Jason P
February 28, 2024 7:16 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Feb 26 Filed by: Atlas Venture Opportunity Fund II, L.P.
February 28, 2024 7:14 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Farwell Wildon
February 28, 2024 5:37 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Feb 28 Filed by: Farwell Wildon
February 28, 2024 5:36 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
February 28, 2024 4:38 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
February 27, 2024 5:24 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
February 26, 2024 4:43 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Feb 21 Filed by: Rhodes Jason P
February 23, 2024 7:00 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Feb 21 Filed by: Atlas Venture Opportunity Fund II, L.P.
February 23, 2024 6:59 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
February 23, 2024 5:29 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
February 23, 2024 5:20 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
February 23, 2024 5:20 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
February 23, 2024 5:16 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Feb 15 Filed by: Rhodes Jason P
February 20, 2024 6:37 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Feb 15 Filed by: Atlas Venture Associates XI, LLC
February 20, 2024 6:36 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
February 20, 2024 5:14 PM - SEC Filing
H.C. Wainwright Starts Dyne Therapeutics (DYN) at Buy
February 20, 2024 6:03 AM - StreetInsider
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
February 15, 2024 5:29 PM - SEC Filing
Form SC 13G/A Dyne Therapeutics, Inc. Filed by: CITADEL ADVISORS LLC
February 14, 2024 4:58 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Feb 12 Filed by: Farwell Wildon
February 14, 2024 4:28 PM - SEC Filing
Dyne Therapeutics Announces Upcoming Presentations on Initial Clinical Data From its ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients at the 2024 Muscular Dystrophy Association Clinical
February 14, 2024 4:16 PM - StreetInsider
Dyne Therapeutics Announces Upcoming Presentations on Initial Clinical Data From its ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients at the 2024 Muscular Dystrophy Association Clinical
February 14, 2024 4:15 PM - Globe NewsWire
Form SC 13G/A Dyne Therapeutics, Inc. Filed by: Deep Track Capital, LP
February 14, 2024 8:40 AM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Farwell Wildon
February 12, 2024 5:40 PM - SEC Filing
Form SC 13G/A Dyne Therapeutics, Inc. Filed by: MPM BIOVENTURES 2018, L.P.
February 12, 2024 4:07 PM - SEC Filing
Form SC 13G/A Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
February 9, 2024 4:10 PM - SEC Filing
Dyne Therapeutics to Present at February Investor Conferences
February 1, 2024 7:30 AM - StreetInsider
Form 4 Dyne Therapeutics, Inc. For: Jan 29 Filed by: Brumm Joshua T
January 31, 2024 4:19 PM - SEC Filing
Form SC 13G Dyne Therapeutics, Inc. Filed by: BlackRock Inc.
January 29, 2024 3:27 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Jan 26 Filed by: Farwell Wildon
January 26, 2024 7:50 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Jan 26 Filed by: McNeill Jonathan
January 26, 2024 7:49 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Jan 26 Filed by: Scalzo Richard William
January 26, 2024 7:48 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Scalzo Richard William
January 26, 2024 7:47 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: McNeill Jonathan
January 26, 2024 7:47 PM - SEC Filing
Dyne Therapeutics Inc. (DYN) Resumes Trading Following Halted, Now Up 36%
January 26, 2024 2:54 PM - StreetInsider
Avidity Biosciences (RNA) Spikes 15% Following Report Dyne Therapeutics Inc. (DYN) Received Takeover Interest
January 26, 2024 2:38 PM - StreetInsider
Dyne Therapeutics Inc. (DYN) Said To Weigh Options Amid Takeover Interest - Bloomberg
January 26, 2024 2:28 PM - StreetInsider
Form SC 13G Dyne Therapeutics, Inc. Filed by: Deep Track Capital, LP
January 19, 2024 4:39 PM - SEC Filing
Form SC 13G/A Dyne Therapeutics, Inc. Filed by: Deep Track Capital, LP
January 19, 2024 9:09 AM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Jan 09 Filed by: Kersten Dirk
January 11, 2024 4:32 PM - SEC Filing
Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
January 11, 2024 4:05 PM - Globe NewsWire
Dyne Therapeutics (DYN) PT Lowered to $27 at Piper Sandler
January 8, 2024 7:17 AM - StreetInsider
Form 424B5 Dyne Therapeutics, Inc.
January 5, 2024 4:07 PM - SEC Filing
Form 8-K Dyne Therapeutics, Inc. For: Jan 04
January 5, 2024 8:02 AM - SEC Filing
Dyne Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
January 5, 2024 7:30 AM - StreetInsider
Dyne Therapeutics Inc. (DYN) Prices 17.15M Share Offering at $17.50/sh
January 5, 2024 5:44 AM - StreetInsider
Dyne Therapeutics Announces Pricing of $300 Million Public Offering of Common Stock
January 4, 2024 10:46 PM - Globe NewsWire
Form 4 Dyne Therapeutics, Inc. For: Jan 03 Filed by: Brumm Joshua T
January 4, 2024 9:50 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Jan 03 Filed by: Beskrovnaya Oxana
January 4, 2024 9:49 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Jan 02 Filed by: McNeill Jonathan
January 4, 2024 9:48 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Jan 03 Filed by: Scalzo Richard William
January 4, 2024 9:47 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Brumm Joshua T
January 4, 2024 9:46 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Beskrovnaya Oxana
January 4, 2024 9:46 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: McNeill Jonathan
January 4, 2024 9:46 PM - SEC Filing
Form S-3MEF Dyne Therapeutics, Inc.
January 4, 2024 9:20 PM - SEC Filing
Dyne Therapeutics (DYN) Suspends ATM Offering
January 4, 2024 5:17 PM - StreetInsider
Form 8-K Dyne Therapeutics, Inc. For: Jan 04
January 4, 2024 5:13 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: McNeill Jonathan
January 3, 2024 8:15 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Scalzo Richard William
January 3, 2024 8:14 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Brumm Joshua T
January 3, 2024 8:14 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Beskrovnaya Oxana
January 3, 2024 8:13 PM - SEC Filing
After-hours movers: MongoDB and Cal-Maine decline, Arena Group surges
January 3, 2024 4:45 PM - StreetInsider
Form 424B5 Dyne Therapeutics, Inc.
January 3, 2024 4:37 PM - SEC Filing
Dyne Therapeutics Inc. (DYN) Announces $175M Proposed Public Offering of Common Stock
January 3, 2024 4:26 PM - StreetInsider
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
January 3, 2024 4:25 PM - Globe NewsWire
Dyne Therapeutics (DYN) PT Raised to $25 at JPMorgan
January 3, 2024 3:59 PM - StreetInsider
Dyne Therapeutics (DYN) PT Raised to $44 at Oppenheimer; 'Expectations Exceeded Across the Board'
January 3, 2024 8:31 AM - StreetInsider
Dyne Therapeutics (DYN) Climbs 100% Following Positive Initial Clinical Data from ACHIEVE Trial in DM1 Patients and DELIVER Trial Data
January 3, 2024 7:08 AM - StreetInsider
Form 8-K Dyne Therapeutics, Inc. For: Jan 03
January 3, 2024 6:38 AM - SEC Filing
Dyne Therapeutics (DYN) Reports Positive Initial Clinical Data from ACHIEVE Trial in DM1 Patients and DELIVER Trial
January 3, 2024 6:30 AM - StreetInsider
Dyne Therapeutics Announces Positive Initial Clinical Data from ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients Demonstrating Promise of the FORCEā¢ Platform in Developing Therapeutic
January 3, 2024 6:30 AM - StreetInsider
Dyne Therapeutics to Host Virtual Event Tomorrow, January 3 at 8:00 AM ET, to Present Initial Clinical Data from ACHIEVE and DELIVER Trials
January 2, 2024 4:05 PM - StreetInsider
Form 144 Dyne Therapeutics, Inc. Filed by: McNeill Jonathan
December 29, 2023 9:04 PM - SEC Filing
Full Article List